Mirror Biologics, Inc. Appoints Carter J. Ward as Chief Financial Officer
Mirror Biologics, Inc. (“Mirror”), a clinical stage biopharmaceutical company today announced the appointment of Carter J. Ward as Chief...
Source: pr.com